Search

Search Constraints

You searched for: Author/Creator Elmets, Craig

Search Results

3. Long‐term disease control and safety with the anti‐CCR4 antibody mogamulizumab: Post‐hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T‐cell lymphoma. Issue 8 (28th June 2022)

4. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Issue 9 (September 2018)

5. On the role of classical and novel forms of vitamin D in melanoma progression and management. Issue 177 (March 2018)